Titin Mutation Is Associated With Tumor Mutation Burden and Promotes Antitumor Immunity in Lung Squamous Cell Carcinoma

Lung squamous cell carcinoma (LUSC) is a leading cause of mobidity and mortality worldwide. Recently, there was a shift in the treatment pattern of immune therapy in LUSC patients; merely a small number of patients with non-small cell lung cancer (NSCLC) at advanced stages respond well to immune che...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Xiaona, Tang, Yemeng, Sheng, Jueqi, Shu, Pingping, Zhu, Xiayan, Cai, Xueding, Zhao, Chengguang, Wang, Liangxing, Huang, Xiaoying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566981/
https://www.ncbi.nlm.nih.gov/pubmed/34746153
http://dx.doi.org/10.3389/fcell.2021.761758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566981/
https://www.ncbi.nlm.nih.gov/pubmed/34746153
http://dx.doi.org/10.3389/fcell.2021.761758

Ejemplares similares